OncoCyte Corp (NASDAQ:OCX)

2.21
Delayed Data
As of 4:00pm ET
 -0.045 / -2.00%
Today’s Change
1.87
Today|||52-Week Range
6.57
-7.74%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$222.3M

Company Description

OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.

Contact Information

OncoCyte Corp.
15 Cushing
Irvine California 92618
P:(949) 409-7600
Investor Relations:

Employees

Shareholders

Individual stakeholders57.72%
Other institutional46.42%
Mutual fund holders12.34%

Top Executives

Ronald Asbury AndrewsPresident, Chief Executive Officer & Director
Gisela PaulsenChief Operating Officer
Mitchell Stuart LevineChief Financial Officer
Douglas T. RossChief Science Officer
Yu LiChief Accounting Officer, VP & Controller